
© 2024 Edison Investment Research
Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,835 | 2,915 | 19:08 | |
2,845 | 2,910 | 19:09 |
Zeit | Aktuelle Nachrichten | |
---|---|---|
14.03. | Oryzon Genomics, S.A.: ORYZON to Provide Corporate Progress Updates at Several Events in March-April | |
05.03. | Oryzon Genomics, S.A.: Oryzon Announces Publication of Study on Phelan-McDermid Syndrome (PMS) Patients, a Form of Autism, Paving the Way for a Novel Personalized Medicine Approach with Vafidemstat | |
05.03. | Oryzon (BME: ORY) publishes results of vafidemstat in PMS | |
04.03. | Oryzon Genomics - All steady heading into 2025 | |
28.02. | ORYZON GENOMICS, S.A.: ORYZON announces the voting results from its Extraordinary General Shareholders' Meeting |